Delivery Order SPE2DB22D1041-SPE2DB25FTZB6

Award Date 1/14/25
Potential Completion Date 1/15/25
Potential Value $29K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,225.05 firm fixed-price contract is for the supply of IMITREX 6 MG/0.5 ML PEN INJECT 0.5ML, a specialty medication. The contract has an ultimate completion date of December 23, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a Delivery Order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Imitrex 6 mg/0.5 mL Injection Pens. The contract has a ceiling value of $3,681.36 and a completion date of May 6, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a large pharmaceutical distributor, for the supply of Imitrex 6 mg/0.5 ml pen injectors. The fixed-price delivery order, valued at $12,343.56, has an ultimate completion date of September 20, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999 through December 2025, to deliver a wide range of medical...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,873.98 firm fixed-price delivery order contract is for the supply of Imitrex 6 mg/0.5 ml pen injections. The contract has an ultimate completion date of February 19, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,710.70, is for the supply of Imitrex 6 mg/0.5 ml pen injections to support military healthcare programs. The contract has an ultimate completion date of May 30, 2024. Amerisourcebergen holds a separate $999,999,999 Indefinite Delivery Contract (IDC)...
This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for IMITREX 4 MG/0.5 ML PEN INJECT 0.5ML. The award has a ceiling value of $11,207.69 and a period of performance through June 4, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical covering a wide range of pharmaceutical products and medical supplies for...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Imitrex 6 mg/0.5 ml pens (0.5 ml) to the U.S. government. The $4,252.98 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of May 30, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to federal agencies, including the Department of Defense (DoD) and the Department of...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides for the delivery of IMITREX 6 MG/0.5 ML PEN INJECT 0.5ML, a specialty pharmaceutical product, with a ceiling value of $5,213.98 and an ultimate completion date of July 1, 2024. The contract is a firm fixed-price delivery order, and there is no set-aside designation. AmerisourceBergen...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is a delivery order with a ceiling value of $2,237.58 under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of Imitrex 6 mg/0.5 ml pen injectors to federal medical facilities. No set-aside designation is specified. Amerisourcebergen holds a $999,999,999 IDC with the DLA Troop Support...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. (doing business as Amerisourcebergen). The contract is for the delivery of a pharmaceutical product, Imitrex 6 mg/0.5 mL pen injections, with a ceiling value of $2,773.68 and a completion date of April 17, 2024. The contract is a Firm Fixed Price Delivery Order, awarded without any set-aside...
  • SPE2DB22D1041
    Indefinite Delivery Contract
  • SPE2DB22D1041-SPE2DB25FTZB6
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Imitrex 6 mg/0.5 ml pens, with a ceiling value of $28,877.09 and a completion date of January 15, 2025. The contract has a firm fixed price pricing type and is not designated with a set-aside.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 5/21/25, 10:13 AM